Devex Examines PEPFAR’s Involvement In, Funding For Nigeria

Devex: Uncertainty over PEPFAR support prompts concerns from HIV advocates in Nigeria
“…Nigeria is key to maintaining control of Africa’s epidemic. But total PEPFAR funding for the country … has dipped … [I]n September 2017, PEPFAR unveiled a new strategy, which identified 13 focus countries where it will accelerate efforts to achieve epidemic control. Nigeria was not among them. … Nigeria wasn’t made a focus country largely because PEPFAR doesn’t understand the breadth and depth of the epidemic, making it difficult to respond equitably, [U.S. Global AIDS Coordinator Deborah Birx, who leads PEPFAR,] said. To better understand the challenges, PEPFAR, along with the Nigerian government, is conducting a $125 million survey to define the epidemiology of HIV in the country, Birx told Devex. … Compounding concerns over PEPFAR funding is the fact that while the initiative was designed to work in tandem with the government, many HIV leaders and implementers say Abuja’s commitment has been insufficient…” (Rotinwa, 7/12).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.